Association Between Antipsychotic Use and COVID-19 Mortality Among People With Serious Mental Illness

Katlyn Nemani; Sarah Conderino; Julia Marx; Lorna E Thorpe; Donald C Goff

doi:10.1001/jamapsychiatry.2021.2503

Association Between Antipsychotic Use and COVID-19 Mortality Among People With Serious Mental Illness

JAMA Psychiatry. 2021 Dec 1;78(12):1391-1393. doi: 10.1001/jamapsychiatry.2021.2503.

Authors

Katlyn Nemani^{1

2}, Sarah Conderino³, Julia Marx¹, Lorna E Thorpe³, Donald C Goff^{1

2}

Affiliations

¹ Department of Psychiatry, New York University Langone Medical Center, New York.
² Nathan Kline Institute for Psychiatric Research, Orangeburg, New York.
³ Department of Population Health, New York University Langone Medical Center, New York.

Abstract

This cohort study investigates whether an association exists between antipsychotic use and mortality in patients with serious mental illness who are diagnosed with COVID-19.

Publication types

Letter

MeSH terms

Adult
Aged
Antipsychotic Agents / adverse effects*
Bipolar Disorder / drug therapy*
COVID-19 / mortality*
Cohort Studies
Female
Humans
Male
Middle Aged
Retrospective Studies
SARS-CoV-2
Schizophrenia / drug therapy*

Substances

Antipsychotic Agents